Ron-Patrick Cadeddu (Ron P Cadeddu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Cathrin Nollmann, Wiebke Moskorz, Christian Wimmenauer, Paul S Jäger, Ron-Patrick Cadeddu, Jörg Timm, Thomas Heinzel, Rainer Haas
Characterization of CD34 + Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol. Cancers 16 (7) (2024)
Cathrin Nollmann, Wiebke Moskorz, Christian Wimmenauer, Paul S Jäger, Ron-Patrick Cadeddu, Jörg Timm, Thomas Heinzel, Rainer Haas
Characterization of CD34 + Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol. Cancers 16 (7) (2024)
Cathrin Nollmann, Wiebke Moskorz, Christian Wimmenauer, Paul S Jäger, Ron-Patrick Cadeddu, Jörg Timm, Thomas Heinzel, Rainer Haas
Characterization of CD34 + Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol. Cancers 16 (7) (2024)
Saskia Mayer, Marie Prechtl, Pia Liebfried, Ron-Patrick Cadeddu, Fabian Stuhldreier, Matthias Kohl, Folker Wenzel, Björn Stork, Sebastian Wesselborg, Peter Proksch, Ulrich Germing, Rainer Haas, Paul S Jäger
First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2',4'-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2',4'-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy. Marine drugs 17 (9) (2019)